ANAPHORE

WIPO WIPO 2009

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark ANAPHORE was filed as Word mark on 05/29/2009 at the World Intellectual Property Organization.

Trademark Details Last update: February 24, 2023

Trademark form Word mark
File reference 1002978
Countries Australia China European Community Japan South Korea
Application date May 29, 2009
Expiration date January 14, 2013

Trademark owner

Suite 101,
10931 North Torrey Pines Road
US

Trademark representatives

1299 Pennsylvania Avenue, NW, Suite 700 Washington DC 20004 US

goods and services

05 Pharmaceutical compositions and preparations for use in therapeutics for human, animal and livestock diseases, namely, use for cardiovascular disease, metabolic disease, autoimmune disease, diabetes, obesity, inflammatory disease, vascular disease, dermatological disease, ocular disease, hematological disease, neurological disease, gastrointestinal disease, respiratory disease, viral and infectious disease, cancer, allergies, allograft rejection, genetic disorders, diseases of the musculoskeletal and nervous system, analgesics and wound healing; pharmaceutical compositions and preparations for the diagnosis, prophylaxis and treatment of human, animal and livestock diseases, namely, cardiovascular disease, metabolic disease, autoimmune disease, diabetes, obesity, inflammatory disease, vascular disease, dermatological disease, ocular disease, hematological disease, neurological disease, gastrointestinal disease, respiratory disease, viral and infectious disease, cancer, allergies, allograft rejection, genetic disorders, diseases of the musculoskeletal and nervous system, analgesics and wound healing; vaccines; pharmaceutical compositions and preparations in the nature of contrast media for use with medical imaging equipment; biological reagents for use in clinical medical and non-clinical medical tests for the diagnosis and measurement of disease progression in human, animal and livestock diseases; biological reagents for use in clinical medical and non-clinical medical imaging; biological reagents for laboratory, clinical medical and non-clinical medical research applications
35 Advertising, marketing and promotional services for the biopharmaceutical industry
42 Pharmaceutical research and development services; biological research and development services; bacteriological research and development services; consulting services in the fields of biotechnology and pharmaceutical research, pertaining to therapeutics, research and development, laboratory testing and diagnostics

Trademark history

Date Document number Area Entry
December 18, 2013 2014/10 Gaz US RAW: Total Ceasing Effect
August 9, 2010 2010/32 Gaz KR Rejection
May 11, 2010 2010/19 Gaz EM Rejection
January 14, 2010 2010/2 Gaz JP Rejection
November 9, 2009 2009/46 Gaz AU Rejection
May 29, 2009 2009/24 Gaz US Registration

ID: 141002978